Treatment News

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Treatment News

January 29, 2014
FDA OKs Oral Isentress to Treat HIV in Children
The FDA has approved a new oral suspension form of the integrase inhibitor Isentress (raltegravir) for pediatric use.
Study Examines Why Partner Violence Is Linked to HIV Risk
New research has examined reasons for the strong connection between intimate partner violence and an elevated risk of HIV acquisition among women.
Study Examines Fluidity of Gay Men’s Risk for HIV Over Time
Gay men may shift in and out of levels of risk for acquiring HIV.
January 28, 2014
Inflammatory Cells Linked to Earlier Death From AIDS, Hep C
Certain inflammatory markers are linked to an earlier death among alcohol abusers with HIV, including those coinfected with hepatitis C.
January 27, 2014
Pharma Groups Conspired to Bolster South African Drug Patents
A leaked email has revealed efforts by the international drug industry to influence reforms to South African intellectual property law.
January 24, 2014
Home-Based HIV Tests May Increase HIV Rates Among Gays
Gay men may face higher rates of HIV if they switch from taking HIV tests in clinics to using home-based tests.
January 23, 2014
Tivicay (Dolutegravir) Is Approved in Europe
The European Commission has approved ViiV Healthcare’s integrase inhibitor Tivicay to treat HIV-positive adults and adolescents older than 12. 
January 21, 2014
Young People With HIV New to Care Have High Viral Loads
One in three young people with HIV have viral loads above 50,000 when they are linked to care, making them more likely to pass along the virus.
Computerized Counseling Ups Adherence, Lowers Risky Sex
A computerized counseling program for people with HIV improves treatment adherence and reduces viral load and risky sexual behavior.
January 17, 2014
HIV Positive With Low CD4s? Keeping Appointments Is Vital
Keeping medical appointments is particularly crucial for HIV-positive people on antiretrovirals (ARVs) who have a low CD4 count.
January 15, 2014
Newer HIV Tests Better Identify Acute Infections
The more recently developed “fourth-generation” HIV tests are far superior to older antibody assays at detecting the virus during acute infection.
Those Newly Diagnosed With HIV, STIs Help Find Other Cases
Asking people recently diagnosed with HIV or an STI to recruit members of their social network for testing can help root out other undiagnosed cases.
January 13, 2014
Obamacare Could Insure 171,000 People With HIV
Nearly 47,000 people with HIV who are in care and an additional 124,000 who are not could gain insurance coverage thanks to Obamacare.
T Memory Stem Cells Are Likely a Cornerstone of HIV Reservoir
Long-living, stem-cell-like immune cells appear to be a bedrock of the viral reservoir that prevents antiretroviral treatment from clearing the virus.
January 10, 2014
HIV-Specific Poison May Complement ARVs
In a mouse study, a toxin engineered to target HIV eliminated infected immune cells in which the virus was replicating despite antiretroviral therapy.
January 09, 2014
CDC Reports 'Troubling Rise' in Syphilis in Gay and Bi Men
The CDC reports a “troubling rise” in syphilis in gay and bisexual men, as well as disproportionate rates of chlamydia and gonorrhea among young people.
January 08, 2014
Another Study Suggests PrEP Doesn’t Lead to Riskier Sex
Taking Truvada as pre-exposure prophylaxis (PrEP) did not lead HIV-negative people in a large study to take increased sexual risks, although there are caveats to these findings.
Giving Short-Term ARVs During Early HIV Infection Has Benefits
Taking a relatively short course HIV therapy during primary infection provides immunological benefits for about a year after interrupting treatment.
January 06, 2014
Longitudinal Studies Shed Light on MSM Per-Contact HIV Risk
An analysis of the risk of HIV transmission posed by specific sexual acts found that younger gay and bisexual men of color have a higher risk.
January 03, 2014
ARVs Lower Advanced Liver Disease in Men With HIV & Hep C
Men coinfected with HIV and hepatitis C are at reduced risk of developing decompensated liver disease after beginning HIV treatment.
Addicts in Treatment Have Less Access to HIV and STI Testing
There has been a drop in the proportion of drug treatment programs offering testing for STIs and HIV, although hepatitis C testing availability remains constant.
More Treatment News

Have news about HIV? Send press releases, news tips and other announcements to

Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

20 Years Ago In POZ

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Has a pet helped you deal with your HIV?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.